Authorizes pharmacists to dispense HIV pre-exposure and post-exposure prophylaxis.
This bill amends the Education Law to expand pharmacist authority to dispense HIV prevention medications. It would allow licensed pharmacists, under rules issued by the Commissioner of Education in consultation with the Commissioner of Health, to dispense HIV post-exposure prophylaxis (PEP) as a starter pack of up to seven days when ordered by a physician or certified nurse practitioner, and to dispense HIV pre-exposure prophylaxis (PrEP) under a non-patient-specific order. For PrEP, the bill requires the dispensed supply to be at least 30 days and no more than 60 days.
The bill also adds detailed conditions that must be met before a pharmacist may dispense PrEP. These include completion of a Department of Health training program, documentation of a recent negative HIV test, screening for symptoms of acute HIV infection and contraindicated medications, limits on how often a patient may receive pharmacist-dispensed PrEP, and provision of written health information and referrals for follow-up care. The bill is designed to make HIV prevention medications more accessible through pharmacies while preserving clinical safeguards and referral pathways to physicians and other providers.
The bill would amend sections of the Education Law governing physician, nurse practitioner, and pharmacist practice, specifically expanding pharmacist dispensing authority for HIV PEP and creating a new pharmacist-dispensing pathway for HIV PrEP. It would also require the Department of Health and Education Department to promulgate implementing regulations and training materials, and it would affect pharmacists, physicians, nurse practitioners, and patients seeking HIV prevention services. In practice, it could increase access to timely HIV prophylaxis, especially in settings where immediate medical appointments are difficult to obtain.
The available record shows no committee transcript or vote history, so there is no direct evidence of debate or formal support/opposition in the materials provided. Based on the bill text, the measure appears to be framed as a public health access expansion with significant safety conditions, suggesting a generally pro-access, prevention-oriented policy approach. The absence of recorded votes or discussion prevents a more specific assessment of legislative sentiment.
The main policy tension in the bill is between expanding access to HIV prevention through pharmacists and maintaining medical oversight and patient safety. Potential points of contention include whether pharmacists should be authorized to dispense PrEP without a direct prescriber visit, the requirement for recent HIV testing and symptom screening, the limits on repeated dispensing, and the training and referral obligations imposed on pharmacists. Any opposition would likely focus on scope-of-practice concerns, implementation burden, or whether the safeguards are sufficient; support would likely emphasize faster access to prevention and reduced barriers to care.